XQ, T., XW, N., HL, X., L, Z., DL, Z., B, C., . . . YZ, Z. (2017). Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction. Dove Medical Press.
Style de citation Chicago (17e éd.)XQ, Tian, Ni XW, Xu HL, Zheng L, ZhuGe DL, Chen B, Lu CT, Yuan JJ, et Zhao YZ. Prevention of Doxorubicin-induced Cardiomyopathy Using Targeted MaFGF Mediated by Nanoparticles Combined with Ultrasound-targeted MB Destruction. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)XQ, Tian, et al. Prevention of Doxorubicin-induced Cardiomyopathy Using Targeted MaFGF Mediated by Nanoparticles Combined with Ultrasound-targeted MB Destruction. Dove Medical Press, 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.